Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Reata's $450 Million Up-Front Haul Sets A Record But Remains An Outlier

Oct 01 2010

Related Content

Pharma: Serious About Change?

Oct 01 2010

Abbott Pays $450MM Up-Front For Rights To Reata's CKD Drug

Sep 23 2010

Related Companies

Reata Pharmaceuticals, Inc.

Abbott

Kyowa Kirin Co., Ltd.

AstraZeneca PLC

Rigel Pharmaceuticals, Inc.

Gyre Therapeutics, Inc.

Nektar Therapeutics

Ionis Pharmaceuticals, Inc.

Sanofi Genzyme

Pfizer Inc.

Medivation, Inc.

Bristol Myers Squibb Company

GSK plc

Genmab A/S

Additional Topics

BioPharmaceutical

More from Archive

More from In Vivo

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window